Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 500

1.

Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP.

Diagn Microbiol Infect Dis. 2019 Jul 5:114861. doi: 10.1016/j.diagmicrobio.2019.06.013. [Epub ahead of print]

PMID:
31427139
2.

A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery.

McMillan EA, Kwon G, Clemenceau JR, Fisher KW, Vaden RM, Shaikh AF, Neilsen BK, Kelly D, Potts MB, Sung YJ, Mendiratta S, Hight SK, Lee Y, MacMillan JB, Lewis RE, Kim HS, White MA.

Cell Chem Biol. 2019 Jul 31. pii: S2451-9456(19)30239-9. doi: 10.1016/j.chembiol.2019.07.008. [Epub ahead of print]

PMID:
31378711
3.

Saprochaete clavata Infections in Patients Undergoing Treatment for Hematological Malignancies: A Report of a Monocentric Outbreak and Review of the Literature.

Stanzani M, Cricca M, Sassi C, Sutto E, De Cicco G, Bonifazi F, Bertuzzi C, Bacci F, Paolini S, Cavo M, Lewis RE.

Mycoses. 2019 Jul 31. doi: 10.1111/myc.12978. [Epub ahead of print]

PMID:
31365161
4.

Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease.

Stanzani M, Sassi C, Battista G, Lewis RE.

Med Mycol. 2019 Jun 1;57(Supplement_3):S274-S286. doi: 10.1093/mmy/myy125.

PMID:
31292659
5.

Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae.

Gaibani P, Lombardo D, Bartoletti M, Ambretti S, Campoli C, Giannella M, Tedeschi S, Conti M, Mancini R, Landini MP, Re MC, Viale P, Lewis RE.

Eur J Clin Microbiol Infect Dis. 2019 Jul 6. doi: 10.1007/s10096-019-03628-6. [Epub ahead of print]

PMID:
31278562
6.

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.

Adler-Moore J, Lewis RE, Brüggemann RJM, Rijnders BJA, Groll AH, Walsh TJ.

Clin Infect Dis. 2019 May 2;68(Supplement_4):S244-S259. doi: 10.1093/cid/ciz064.

7.

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B.

Groll AH, Rijnders BJA, Walsh TJ, Adler-Moore J, Lewis RE, Brüggemann RJM.

Clin Infect Dis. 2019 May 2;68(Supplement_4):S260-S274. doi: 10.1093/cid/ciz076.

8.

Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections.

Walsh TJ, Lewis RE, Adler-Moore J.

Clin Infect Dis. 2019 May 2;68(Supplement_4):S241-S243. doi: 10.1093/cid/ciz091. No abstract available.

9.

Live Monitoring and Analysis of Fungal Growth, Viability, and Mycelial Morphology Using the IncuCyte NeuroTrack Processing Module.

Wurster S, Kumaresan PR, Albert ND, Hauser PJ, Lewis RE, Kontoyiannis DP.

MBio. 2019 May 28;10(3). pii: e00673-19. doi: 10.1128/mBio.00673-19.

10.

O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3.

Li X, Gong W, Wang H, Li T, Attri KS, Lewis RE, Kalil AC, Bhinderwala F, Powers R, Yin G, Herring LE, Asara JM, Lei YL, Yang X, Rodriguez DA, Yang M, Green DR, Singh PK, Wen H.

Immunity. 2019 Apr 16;50(4):1115. doi: 10.1016/j.immuni.2019.03.008. No abstract available.

11.

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE.

J Infect. 2019 Jun;78(6):484-490. doi: 10.1016/j.jinf.2019.04.002. Epub 2019 Apr 8.

PMID:
30974130
12.

O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3.

Li X, Gong W, Wang H, Li T, Attri KS, Lewis RE, Kalil AC, Bhinderwala F, Powers R, Yin G, Herring LE, Asara JM, Lei YL, Yang X, Rodriguez DA, Yang M, Green DR, Singh PK, Wen H.

Immunity. 2019 Mar 19;50(3):576-590.e6. doi: 10.1016/j.immuni.2019.01.007. Epub 2019 Feb 12. Erratum in: Immunity. 2019 Apr 16;50(4):1115.

PMID:
30770249
13.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

14.

Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study.

Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Cerenzia MT, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group.

Clin Infect Dis. 2019 Jan 14. doi: 10.1093/cid/ciz032. [Epub ahead of print]

PMID:
30649218
15.

Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.

Giannella M, Pascale R, Ferraro G, Toschi A, Pancaldi L, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P.

Int J Antimicrob Agents. 2019 May;53(5):574-581. doi: 10.1016/j.ijantimicag.2019.01.005. Epub 2019 Jan 9.

PMID:
30639527
16.

ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.

Neilsen BK, Frodyma DE, McCall JL, Fisher KW, Lewis RE.

PLoS One. 2019 Jan 10;14(1):e0209224. doi: 10.1371/journal.pone.0209224. eCollection 2019.

17.

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.

Stanzani M, Lewis RE.

J Fungi (Basel). 2018 Dec 19;4(4). pii: E141. doi: 10.3390/jof4040141. Review.

18.

Correction: KSR1 is required for cell cycle reinitiation following DNA damage.

Razidlo GL, Johnson HJ, Stoeger SM, Cowan KH, Bessho T, Lewis RE.

J Biol Chem. 2018 Dec 7;293(49):19136. doi: 10.1074/jbc.AAC118.006696. No abstract available.

19.

Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Wurster S, Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01896-18. doi: 10.1128/AAC.01896-18. Print 2019 Feb.

20.

The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis.

Bartoletti M, Lewis RE, Giannella M, Tedeschi S, Viale P.

Expert Rev Anti Infect Ther. 2018 Oct;16(10):771-779. doi: 10.1080/14787210.2018.1523716. Epub 2018 Sep 26. Review.

PMID:
30221562
21.

The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.

Jiang C, Bi C, Jiang X, Tian T, Huang X, Wang C, Fernandez MR, Iqbal J, Chan WC, McKeithan TW, Lewis RE, Fu K.

Br J Haematol. 2019 May;185(3):616-620. doi: 10.1111/bjh.15591. Epub 2018 Sep 10. No abstract available.

PMID:
30198569
22.

WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.

Neilsen BK, Chakraborty B, McCall JL, Frodyma DE, Sleightholm RL, Fisher KW, Lewis RE.

BMC Cancer. 2018 Jun 20;18(1):673. doi: 10.1186/s12885-018-4580-6.

23.

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Lionakis MS, Lewis RE, Kontoyiannis DP.

Clin Infect Dis. 2018 Oct 30;67(10):1621-1630. doi: 10.1093/cid/ciy473.

PMID:
29860307
24.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

25.

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.

Gaibani P, Campoli C, Lewis RE, Volpe SL, Scaltriti E, Giannella M, Pongolini S, Berlingeri A, Cristini F, Bartoletti M, Tedeschi S, Ambretti S.

J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529. doi: 10.1093/jac/dky082.

PMID:
29566151
26.

Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis.

Fernandez IJ, Crocetta FM, Demattè M, Farneti P, Stanzani M, Lewis RE, Fornaciari M, Pasquini E, Sciarretta V.

Otolaryngol Head Neck Surg. 2018 Aug;159(2):386-393. doi: 10.1177/0194599818765744. Epub 2018 Mar 20.

PMID:
29558254
27.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

28.

A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.

Das B, Neilsen BK, Fisher KW, Gehring D, Hu Y, Volle DJ, Kim HS, McCall JL, Kelly DL, MacMillan JB, White MA, Lewis RE.

Sci Rep. 2018 Feb 28;8(1):3770. doi: 10.1038/s41598-018-22090-6.

29.

Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa.

Tam VH, Pérez C, Ledesma KR, Lewis RE.

Microbiol Immunol. 2018 Apr;62(4):291-294. doi: 10.1111/1348-0421.12581. Epub 2018 Mar 26.

PMID:
29418013
30.

Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).

Di Blasi R, Cattaneo C, Lewis RE, Tumbarello M, Angelici L, Dragonetti G, Busca A, Cambò B, Candoni A, Cesarini M, Cesaro S, Delia M, Fanci R, Farina F, Garzia M, Giordano A, Martino B, Melillo L, Nadali G, Perriello V, Picardi M, Quinto AM, Salutari P, Spolzino A, Vacca A, Vetro C, Zancanella M, Nosari A, Aversa F, Pagano L; on the behalf of the SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Ann Hematol. 2018 May;97(5):791-798. doi: 10.1007/s00277-018-3252-6. Epub 2018 Feb 7.

PMID:
29411126
31.

Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.

Bartoletti M, Tedeschi S, Pascale R, Raumer L, Maraolo AE, Palmiero G, Tumietto F, Cristini F, Ambretti S, Giannella M, Lewis RE, Viale P.

Int J Antimicrob Agents. 2018 Mar;51(3):516-521. doi: 10.1016/j.ijantimicag.2018.01.010. Epub 2018 Feb 2.

PMID:
29410250
32.

Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study.

Giannella M, Pascale R, Toschi A, Ferraro G, Graziano E, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P.

Clin Microbiol Infect. 2018 Oct;24(10):1077-1083. doi: 10.1016/j.cmi.2018.01.013. Epub 2018 Jan 31.

PMID:
29371138
33.

Overview of antifungal dosing in invasive candidiasis.

Pea F, Lewis RE.

J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i33-i43. doi: 10.1093/jac/dkx447. Review.

PMID:
29304210
34.

The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Sassi C, Stanzani M, Lewis RE, Facchini G, Bazzocchi A, Cavo M, Battista G.

Br J Radiol. 2018 Feb;91(1083):20170220. doi: 10.1259/bjr.20170220. Epub 2018 Jan 10.

35.

In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.

Gaibani P, Lewis RE, Volpe SL, Giannella M, Campoli C, Landini MP, Viale P, Re MC, Ambretti S.

Int J Infect Dis. 2017 Dec;65:1-3. doi: 10.1016/j.ijid.2017.09.017. Epub 2017 Sep 22.

36.

Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.

Lewis RE, Verweij PE.

J Infect Dis. 2017 Aug 15;216(suppl_3):S466-S473. doi: 10.1093/infdis/jix222. Review.

PMID:
28911046
37.

Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.

Rizzello I, Castagnetti F, Toschi PG, Bertaccini P, Primavera L, Paolucci M, Faccioli L, Spinardi L, Lewis RE, Cavo M, Stanzani M.

Mycoses. 2018 Jan;61(1):53-60. doi: 10.1111/myc.12697. Epub 2017 Sep 22. Review.

PMID:
28872724
38.

Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.

Giannella M, Trecarichi EM, Giacobbe DR, De Rosa FG, Bassetti M, Bartoloni A, Bartoletti M, Losito AR, Del Bono V, Corcione S, Tedeschi S, Raffaelli F, Saffioti C, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viscoli C, Lewis RE, Viale P, Tumbarello M; Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva (ISGRI-SITA).

Int J Antimicrob Agents. 2018 Feb;51(2):244-248. doi: 10.1016/j.ijantimicag.2017.08.019. Epub 2017 Aug 24.

PMID:
28842283
39.

Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.

Stanzani M, Vianelli N, Cavo M, Maritati A, Morotti M, Lewis RE.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02651-16. doi: 10.1128/AAC.02651-16. Print 2017 Sep.

40.

Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study.

Giannella M, Graziano E, Marconi L, Girometti N, Bartoletti M, Tedeschi S, Tumietto F, Cristini F, Ambretti S, Berlingeri A, Lewis RE, Viale P.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1965-1970. doi: 10.1007/s10096-017-3020-x. Epub 2017 Jun 1.

PMID:
28567543
41.

A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C.

Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.

42.

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.

43.

Characterization of antibody response in neuroinvasive infection caused by Toscana virus.

Pierro A, Ficarelli S, Ayhan N, Morini S, Raumer L, Bartoletti M, Mastroianni A, Prati F, Schivazappa S, Cenni P, Vocale C, Rossini G, Gaibani P, Sambri V, Landini MP, Lewis RE, Charrel RN, Varani S.

Clin Microbiol Infect. 2017 Nov;23(11):868-873. doi: 10.1016/j.cmi.2017.03.017. Epub 2017 Mar 23.

44.

KSR as a therapeutic target for Ras-dependent cancers.

Neilsen BK, Frodyma DE, Lewis RE, Fisher KW.

Expert Opin Ther Targets. 2017 May;21(5):499-509. doi: 10.1080/14728222.2017.1311325. Epub 2017 Apr 7. Review.

45.

Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis.

Guo L, Costanzo-Garvey DL, Smith DR, Neilsen BK, MacDonald RG, Lewis RE.

Mol Metab. 2016 Dec 18;6(2):194-205. doi: 10.1016/j.molmet.2016.12.004. eCollection 2017 Feb.

46.

Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.

Bartoletti M, Martelli G, Tedeschi S, Morelli M, Bertuzzo V, Tadolini M, Pianta P, Cristini F, Giannella M, Lewis RE, Pinna AD, Viale P.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12658. Epub 2017 Mar 11. Review.

PMID:
28054732
47.

Preface.

Gould FK, Lewis RE, Richardson MD.

J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii1. No abstract available.

PMID:
27880662
48.

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

Polverelli N, Breccia M, Benevolo G, Martino B, Tieghi A, Latagliata R, Sabattini E, Riminucci M, Godio L, Catani L, Nicolosi M, Perricone M, Sollazzo D, Colafigli G, Campana A, Merli F, Vitolo U, Alimena G, Martinelli G, Lewis RE, Vianelli N, Cavo M, Palandri F.

Am J Hematol. 2017 Jan;92(1):37-41. doi: 10.1002/ajh.24572. Epub 2016 Nov 12.

49.

Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?

Lewis RE.

Virulence. 2017 Jan 2;8(1):13-14. doi: 10.1080/21505594.2016.1231756. Epub 2016 Sep 3. No abstract available.

50.

Cell non-autonomous regulation of hepatic IGF-1 and neonatal growth by Kinase Suppressor of Ras 2 (KSR2).

Guo L, Costanzo-Garvey DL, Smith DR, Zavorka ME, Venable-Kang M, MacDonald RG, Lewis RE.

Sci Rep. 2016 Aug 26;6:32093. doi: 10.1038/srep32093.

Supplemental Content

Loading ...
Support Center